Q1 2016 13F Holders as of 3/31/2016
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
51.1M
-
Number of holders
-
62
-
Total 13F shares, excl. options
-
16.6M
-
Shares change
-
+596K
-
Total reported value, excl. options
-
$180M
-
Value change
-
+$4.02M
-
Number of buys
-
32
-
Number of sells
-
-27
-
Price
-
$10.80
Significant Holders of REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) as of Q1 2016
75 filings reported holding RGNX - REGENXBIO Inc. - Common Stock, par value $0.0001 per share as of Q1 2016.
REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) has 62 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16.6M shares
of 51.1M outstanding shares and own 32.52% of the company stock.
Largest 10 shareholders include FMR LLC (3.08M shares), BROOKSIDE CAPITAL MANAGEMENT LLC (1.93M shares), DEERFIELD MANAGEMENT CO (1.17M shares), VHCP Management II, LLC (1.03M shares), Vivo Capital, LLC (990K shares), RS INVESTMENT MANAGEMENT CO LLC (978K shares), PRICE T ROWE ASSOCIATES INC /MD/ (977K shares), PERCEPTIVE ADVISORS LLC (825K shares), Sectoral Asset Management Inc (680K shares), and QVT Financial LP (424K shares).
This table shows the top 62 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.